Effects of Chemotherapy: Clinical Trials

3 trials for Effects of Chemotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2

Follow Effects of Chemotherapy: new trials by email Literature Review of Effects of Chemotherapy trials Research Report on Effects of Chemotherapy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Neo-adjuvant Erbitux-based chemotherapy - Locally Advanced Malignant Neoplasm, Oral Cancer
Phase 2 / Phase 3CompletedShanghai Jiao Tong University School of Medicine2432011-08-012017-08-21
Cryotherapy Intervention for Docetaxel-induced Nail Toxicities
Frozen gel glove (Elasto-Gel Mitten) - Effects of Chemotherapy
Phase 2 / Phase 3CompletedPrincess Alexandra Hospital, Brisbane, Australia652010-10-012012-12-05
Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation
Bortezomib, cyclophosphamide, thalidomide, dexamethasone - Multiple Myeloma, Effects of Chemotherapy
Phase 3CompletedGrupo de Estudos Multicentricos em Onco-Hematologia3112009-06-152018-01-18

Narrower conditions

Mouth Neoplasms (1)  ·  Multiple Myeloma (1)  ·  Oropharyngeal Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphoproliferative Disorders (1)  ·  Mouth Diseases (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Plasma Cell (1)

Interventions

Bortezomib (1)  ·  Calcium Dobesilate (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Radiotherapy (1)  ·  Thalidomide (1)

Sponsors

Grupo de Estudos Multicentricos em Onco-Hematologia (1)  ·  Princess Alexandra Hospital, Brisbane, Australia (1)  ·  Shanghai Jiao Tong University School of Medicine (1)

Countries

Australia (1)  ·  China (1)

Top investigators

Alexandra McCarthy, PhD (1)  ·  Chen-ping Zhang, MD, PhD (1)  ·  Edvan Cusoe, MD (1)

Results publications

PMID 24362908